Why Some ODF Lines Qualify in Days and Others Take Weeks
Share
In oral dissolvable film (ODF) projects, many companies encounter the same paradox:
- two lines may use similar-looking equipment and formulations,
- but one reaches a stable state and moves into validation within days,
- while another spends weeks fighting thickness swings, surface defects and unstable yield.
This gap is not always about team capability. More often, it reflects whether the equipment design respects the behaviour of ODF in the wet-film stage. Among all design choices, the drying concept is one of the most underestimated factors.
In Trials, Time Is Spent on Fighting Instability – Not Just “Setting Parameters”
Slow ODF commissioning rarely means the process route is unclear. It usually means the system itself is inherently unstable:
- engineers think they are “optimising parameters”,
- but in reality they are constantly trying to suppress random process noise.
A major source of this noise is the drying section. While the film is still wet and not yet set, airflow and tension can disturb the layer, creating thickness variation from the very beginning.
For a deeper dive into how drying affects uniformity and stability, see HUANGHAI’s article on ODF drying, thickness uniformity and quality .
Vertical Oven-Style Airflow: Treating a Wet Film as If It Were Already Solid
The intuitive logic of vertical oven-style drying is clear: strong airflow, fast evaporation. However, applied to ODF, the system is actually acting on a wetted, structurally weak film:
- air jets can “break up” the wet film before it sets,
- local pooling and thinning occur as material is pushed around,
- the result is built-in thickness non-uniformity and surface defects.
On the trial floor, this shows up as:
- extremely narrow operating windows,
- small changes in fan speed or exhaust balance causing instability,
- operations that feel like “walking on a cliff edge” based on experience rather than robust design.
Why Commissioning Becomes a Labour-Intensive Project
When the system design itself tends to disturb the wet film, teams are forced into a highly manual mode of working just to keep the line under control:
- continuously adjusting air volume, exhaust ratios and temperature,
- tweaking line speed, web tension and roller strategies,
- making compromises to stabilise thickness instead of optimising efficiency.
This does more than extend the trial period. It also means:
- parameters are difficult to lock into a robust, transferable SOP,
- scale-up becomes risky because “what works” may not be clearly documented,
- critical know-how is concentrated in a few people, increasing operational risk.
In other words, commissioning turns into a person-dependent craft rather than a repeatable engineering project.
Parallel Hot-Air Drying: Reducing Noise at the Source
Parallel hot-air drying takes a different approach. Instead of blowing directly onto the wet film, it aligns the main airflow with the web direction and uses more gentle, continuous convection.
The value of this concept is not just higher efficiency – it is less destructive interaction with the wet film:
- the wet layer is much less likely to be disturbed or “blown apart”,
- thickness uniformity forms more naturally along the web,
- the process window becomes wider and easier to control.
As a result, the focus of commissioning shifts:
- from “constantly suppressing random fluctuations”
- to “optimising line speed, energy use and overall efficiency”.
HUANGHAI’s gradient hot-air concepts for ODF – which use a natural temperature progression along the tunnel – build this stability into the line design itself. For more on gradient drying and its impact on yield and stability, see this related article .
What This Means for the Business: Results, Not Just Theory
Choosing a more stable drying approach is not an abstract engineering preference. It translates into very concrete benefits for the company:
- Shorter commissioning time – trial phases measured in days, not weeks or months.
- Lower dependence on “hero engineers” – more of the stability comes from design, not from individual skill.
- Reduced scale-up risk – parameters from pilot runs can be transferred with fewer surprises.
- More controllable validation and routine production – less firefighting, more predictable output.
In competitive markets, these differences directly affect time-to-market, project cost and the ability to launch new ODF products with confidence.
Conclusion: Is the System Asking You to “Tune Hard”?
The difference between fast and slow ODF commissioning is often not whether the team is talented enough to “dial in” a good process. It is whether the system itself requires constant effort just to stay stable.
When the drying design reduces disturbance at the wet-film stage, trials stop being a long, exhausting battle against noise and start to look like what they should be: a repeatable engineering project that can be documented, validated and scaled.
If you are planning a new ODF line or troubleshooting a project stuck in never-ending trials, it may be time to look beyond formulation and coating and ask a simple question: what is our drying concept really doing to the wet film?
Contact HUANGHAI to discuss ODF drying and line configuration options that are designed for fast, stable commissioning.
Explore related equipment: ODF film coating machine | pharmaceutical testing instruments.
Frequently Asked Questions
Q: What is the difference between an ODF film and a transdermal patch?
A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.
Q: What production output can I expect from a Huanghai ODF machine?
A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.
Q: What drying technology does Huanghai use for ODF production?
A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.
Q: What are the GMP requirements for ODF production equipment?
A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.
Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?
A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.